HHS Considers Two Ways To Overhaul Medicare Drug Rebates; Azar Leans Toward The One Pharma Opposes

HHS is weighing two opposing approaches for dealing with Medicare drug rebates -- doing away with rebates or making plans share them at the pharmacy counter -- and HHS Secretary Alex Azar seems to be leaning toward the former, which drug makers do not like. Both proposals are mentioned in President Donald Trump’s newly unveiled plan to control prescription drug costs, but it is difficult to tease out which policies in the plan are merely thought experiments and which ones...